Grace Therapeutics
GRCE
12 hedge funds and large institutions have $4.63M invested in Grace Therapeutics in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
50% more funds holding
Funds holding: 8 → 12 (+4)
46% less capital invested
Capital invested by funds: $8.53M → $4.63M (-$3.89M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$117K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$56K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$53.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.1K |
| 5 |
Citigroup
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
-$2.08M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.93M |
| 3 |
EEG
E.E. Geduld
|
-$31K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$609 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $3.3M | -$1.93M | -3,167 | -35% |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $1.13M | +$53.6K | +88 | +5% |
|
|
3
Citadel Advisors
Miami,
Florida
| $106K | +$117K | +192 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| $50K | +$56K | +92 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $20K | +$23.1K | +38 | New |
|
|
6
Citigroup
New York
| $12K | +$12.8K | +21 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $9K | +$10.4K | +17 | New |
|
|
U
8
UBS
Zurich,
Switzerland
| $3K | +$3.05K | +5 | New |
|
|
EWM
9
Edge Wealth Management
New York
| $2K | – | – | – |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
11
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | -$609 | -1 | -50% |
|
|
CP
12
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | +$1.83K | +3 | New |
|
|
IIM
13
Intact Investment Management
Montreal,
Quebec, Canada
| – | -$2.08M | -3,333 | Closed |
|
|
EEG
14
E.E. Geduld
| – | -$31K | -52 | Closed |
|
GRCE Hedge Fund Activity: Q1 2014 in Review
12 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2014, worth a combined $4.63M — down 46% from $8.53M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GRCE positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $117K. The largest seller was Intact Investment Management, exiting entirely with an estimated $2.08M sold.
- 12 institutional investors held Grace Therapeutics (GRCE) as of Q1 2014, up from 8 in Q4 2013.
- Funds reported $4.63M of Grace Therapeutics stock for Q1 2014, down 46% quarter-over-quarter.
- 7 funds opened new Grace Therapeutics positions in Q1 2014 and 3 closed out, a net change of +4 holders.
- The largest Grace Therapeutics buyer in Q1 2014 was Citadel Advisors, an estimated $117K added.
- The largest Grace Therapeutics seller in Q1 2014 was Intact Investment Management, an estimated $2.08M sold.
Based on aggregated 13F filings for Q1 2014.